Connection
Sarah Parker to Antitubercular Agents
This is a "connection" page, showing publications Sarah Parker has written about Antitubercular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.107 |
|
|
|
-
Marais BJ, Parker SK, Verver S, van Rie A, Warren RM. Primary and postprimary or reactivation tuberculosis: time to revise confusing terminology? AJR Am J Roentgenol. 2009 Apr; 192(4):W198; author reply W199-200.
Score: 0.067
-
Kim S, Yamada WM, Duncanson B, Nole J, Rogers S, Parker S, Bacci M, Mtchedlidze N, Peloquin CA, Louie A, Schmidt S, Drusano GL, Neely MN. Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase. Antimicrob Agents Chemother. 2021 09 17; 65(10):e0069321.
Score: 0.039